Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 1717 News Items found In the Lab Why Do Brain Tumors Often Return After Treatment? MSK Researchers Say Stem Cells May Be Key Tuesday, January 11, 2022 In a new study, MSK researchers looked at why glioblastoma brain tumors usually come back after treatment. Their findings suggest that a subset of cells — cancer stem cells — are able to evade current treatments because they are not actively dividing, and that these cells later form new tumors. Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy Thursday, January 6, 2022 A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia. Feature How a Mishap in Early Development Can Lead to a Lifetime of Cancer Risk Wednesday, January 5, 2022 MSK researchers have found mutations that arise in embryos can convey a risk of cancer that’s similar to what’s seen in people with inherited cancer mutations. New Research Shows the HPV Cancer Vaccine Saves Lives Monday, January 3, 2022 Learn why MSK recommends that children be vaccinated against HPV. From Breaks to Breakthroughs Saturday, January 1, 2022 Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work. Looking for Patterns in Cancer Survivors Saturday, January 1, 2022 Cancer treatment is complex. For every type of cancer, there is a range of treatments, side effects, and outcomes. Machine learning can help make sense of these variables, according to Quaid Morris. Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic Saturday, January 1, 2022 MSK researchers are making important inroads in understanding and treating pancreatic cancer. Sloan Kettering Institute Scientists Retool CAR T Cells to Serve as ‘Micropharmacies’ for Cancer Drugs Thursday, December 30, 2021 These souped-up versions may help overcome some limitations of existing CAR T cells. Memorial Sloan Kettering and the Chinese Thoracic Oncology Group Discuss Opportunities for Further Collaboration to Accelerate International Clinical Trials During Annual Symposium Monday, December 27, 2021 Building on their long-term shared commitment to international collaboration on cancer research and care – Memorial Sloan Kettering Cancer Center (MSK)... 2021 in Review: 10 Important Clinical Advances in Cancer at MSK Wednesday, December 22, 2021 Learn about some of the most important clinical advances made at MSK in 2021. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer